BRUKER CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
BRUKER CORPORATION (BRKR) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 3.82% for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2025-03-03
- BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2024 was 3.82%, a 10.75% decline from fiscal 2023.
- BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2023 was 4.28%, a 41.25% increase from fiscal 2022.
- BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2022 was 3.03%, a 388.71% increase from fiscal 2021.
- BRUKER CORPORATION share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2021 was 0.62%, a 169.57% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|
| 2024-12-31 | 3.82% 10-K · filed 2025-03-03 | |
| 2023-12-31 | 4.28% 10-K · filed 2025-03-03 | |
| 2022-12-31 | 3.03% 10-K · filed 2025-03-03 | |
| 2022-09-30 | 3.03% 10-Q · filed 2022-11-04 | |
| 2021-12-31 | 0.62% 10-K · filed 2024-02-29 | |
| 2021-09-30 | 0.62% 10-Q · filed 2022-11-04 | |
| 2020-12-31 | 0.23% 10-K · filed 2023-03-01 | |
| 2020-09-30 | 0.23% 10-Q · filed 2021-11-05 | |
| 2019-12-31 | 1.55% 10-K · filed 2022-02-28 | |
| 2019-09-30 | 1.55% 10-Q · filed 2020-11-06 | |
| 2018-12-31 | 2.80% 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |